$2.23 Billion is the total value of SECTORAL ASSET MANAGEMENT INC's 64 reported holdings in Q4 2014. The portfolio turnover from Q3 2014 to Q4 2014 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ANTH | Exit | ANTHERA PHARMACEUT | $0 | – | -247,961 | -100.0% | -0.02% | – |
| PRQR | Exit | PROQR THRAPEUTICS | $0 | – | -70,000 | -100.0% | -0.05% | – |
| AMBI | Exit | AMBIT BIOSCIENCES | $0 | – | -146,111 | -100.0% | -0.10% | – |
| CI | Exit | CIGNA CORP | $0 | – | -103,164 | -100.0% | -0.39% | – |
| TRNX | Exit | TORNIER N V | $0 | – | -469,023 | -100.0% | -0.47% | – |
| BSX | Exit | BOSTON SCIENTIFIC | $0 | – | -1,047,166 | -100.0% | -0.52% | – |
| THRX | Exit | THERAVANCE INC | $0 | – | -971,438 | -100.0% | -0.70% | – |
| F113PS | Exit | COVIDIEN PLC | $0 | – | -232,358 | -100.0% | -0.85% | – |
| INSM | Exit | INSMED INC | $0 | – | -1,625,323 | -100.0% | -0.89% | – |
| CMRX | Exit | CHIMERIX INC | $0 | – | -842,149 | -100.0% | -0.98% | – |
| IMGN | Exit | IMMUNOGEN INC | $0 | – | -2,269,597 | -100.0% | -1.01% | – |
| ABBV | Exit | ABBVIE INC | $0 | – | -444,107 | -100.0% | -1.08% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-02-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BIOMARIN PHARMAC INC | 45 | Q2 2024 | 6.7% |
| DR REDDYS LABS LTD | 45 | Q2 2024 | 2.0% |
| PTC THERAPEUTICS INC | 43 | Q2 2024 | 2.7% |
| GILEAD SCIENCES INC | 41 | Q2 2024 | 8.4% |
| VERTEX PHARMACEUTICL | 41 | Q2 2024 | 6.0% |
| INCYTE CORPORATION | 41 | Q2 2024 | 5.2% |
| AMICUS THERAPEUTICS INC | 40 | Q2 2024 | 6.6% |
| PFIZER INC | 38 | Q2 2024 | 6.3% |
| MERCK & CO. INC | 37 | Q2 2024 | 6.4% |
| MEDTRONIC PLC | 36 | Q2 2024 | 4.4% |
View SECTORAL ASSET MANAGEMENT INC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| eFFECTOR Therapeutics, Inc. | February 14, 2024 | 2,382,644 | 3.7% |
| Galera Therapeutics, Inc.Sold out | February 14, 2024 | 0 | 0.0% |
| Aprea Therapeutics, Inc. | February 12, 2021 | 163,681 | 0.8% |
| LA JOLLA PHARMACEUTICAL CO | February 13, 2020 | ? | ? |
| COLLEGIUM PHARMACEUTICAL, INC | February 13, 2018 | 1,426,862 | 4.4% |
| Advaxis, Inc. | February 10, 2017 | 690,074 | 1.7% |
| AMICUS THERAPEUTICS INC | February 10, 2017 | 5,100,198 | 3.6% |
| OncoMed Pharmaceuticals Inc | February 12, 2016 | ? | ? |
| IRONWOOD PHARMACEUTICALS INC | February 13, 2015 | ? | ? |
| SEQUENOM INC | February 12, 2014 | ? | ? |
View SECTORAL ASSET MANAGEMENT INC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-08-13 |
| N-PX | 2024-08-09 |
| 13F-HR | 2024-05-14 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| SC 13G/A | 2023-02-13 |
View SECTORAL ASSET MANAGEMENT INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.